A prenatal diagnosis was performed in a family with Xlinked adrenoleukodystrophy (ALD). A fetus was at high risk of suffering the disease by segregation analysis and by very long chain fatty acid-CoA synthetase activity assay. A transition (G to A) at codon 617 of the candidate ALD gene was detected by reverse transcription PCR (RT-PCR) based sequencing of the fetal liver RNA. The mutation was located in highly conserved ATP-binding site in this gene and deduced amino acid transversion R617H was thought to be the cause of ALD in this family.
INTRODUCTION
X-linked adrenoleukodystrophy (ALD) is characterized by progressive neurological deterioration, adrenal insufficiency and the accumulation of very long chain fatty acid (VLCFA) in various tissues and body fluid. The clinical picture varies within a family. There are three major types, progressive adrenoleukodystrophy in childhood, adrenomyeloneuropathy (AMN) in adult, and Addison's disease (Moser and Moser, 1989) . The gene for ALD is on the long arm of X chromosome, Xq28 (Human Gene Mapping 11). The cause of ALD has been ascribed to the deficiency of VLCFA-CoA synthetase which is located in peroxisome and functions as a key enzyme for the VLCFA beta-oxidation pathway. Recently, a candidate gene for X-linked ALD has been isolated and some patients have deletion in the gene (Mosser et al., 1993) . The isolated "ALD gene" was different from the VLCFA-CoA synthetase gene itself but belonged to the ATP-binding cassette transporter superfamily.
Here, we report a prenatal diagnosis in a family with AMNtALD and presymptomatic ALD by the detection of a point mutation in the ALD gene.
MATERIALS AND METHODS
The proband (ii-2) was a 60 years old man with AMN. His two daughters (1II-2, 4) were carriers and his grandson (1V-2) was suspected to be a pre-symptomatic ALD (Fig. 1 ) by serum VLCFA assay (Tsuji et al., 1981) . A fetus (IV-l) was consulted to us for prenatal diagnosis. At 15 weeks of gestation amniocentesis was performed and amniocytes were cultured and used for karyotyping, DNA analysis and VLCFA-CoA synthetase assay. DNA was extracted also from peripheral leukocytes of some of the family members. RNA was extracted from the liver of the aborted fetus. For a VLCFA-CoA synthetase assay, lignoceroyl-CoA synthetase activity was measured as described previously (Suzuki et al., 1991 Pedigree of ALD/AMN family. II-1, 2, 9 are AMN patients, iII-6, 13 are ALD patients who were dead and confirmed the diagnosis by autopsy. IV-2 is a pre-symptomatic ALD patients. IV-1 is the fetus consulted for prenatal diagnosis.
transferase (HPRT), and GABA receptor alpha (GABARA) genes. DNA segments of DXS424, DXSI02, DXS300, DXS425 for dinucleotide repeat polymorphism, and DXS52 (Stl4) for variable number tandem repeat (VNTR) polymorphism (Richards et al., 1991) . Each primer was synthesized by Gene Assembler Plus (Pharmacia LKB) depending on the reported sequence data (Human Gene Mapping ll, 1991). PCR was done as described previously (Kinoshita et al., 1991) with minor modifications of annealing temperature depending on each primer set. For FVIII and FIX RFLPs an aliquot of PCR product was digested with HindlII or HhaI.
RT-PCR and sequencing. The ALD cDNA was synthesized by RT-PCR and subcloned in a plasmid vector pSPT18 (Boehringer, Germany). Each primer sequence for RT-PCR were as following; 5 (5'-CTGCGCTACATGCACTCG-3'), 6 (5'-GTGACGATGGGGATGTTCTCG-3'), 7 (5'-GAACATCCCCATCGTCAC-GCC-3'), and 10 (5'-CCTTGGCCGCCTGGAAGATC-3'). The sequence was analyzed with Silver' Sequence TM Kit (Promega, USA) using SP6 or T7 primer as recommended by manufacturer. Electrophoresis was performed on a denaturing gel at 2,400 V for 4 h, then silver stained gel was photographed by a Poraloid camera.
Restriction enzyme digestion of ALD7/IO. RNA was extracted from autopsied normal adrenal gland and used for RT-PCR. ALDT/10 PCR products from the fetal liver and the normal adrenal gland was digested with AciI and AflIII, then electrophoresis was performed on a 6 ~ polyacrylamide gel.
RESULTS
Karyotyping. The karyotype of the fetus was 46,XY. DNA analysis. Each DNA fragment was amplified using 4 sets of primers on Y chromosome (data not shown). The FIX gene RFLP was informative: The proband was hemizygous for the 150 bp + 80 bp allele. His wife (II-3) was homozygous for the 230 bp allele. The pregnant daughter and her sister had both of the alleles. The pre-symptomatic ALD patient and the fetus were hemizygous for the 150 bp+80 bp allele (Fig. 2) . The Stl4 VNTR polymorphism showed similar result, namely, the proband's allele was transmitted to the pre-symptomatic patient and the fetus (data not shown). Other DNA markers were not informative in this family.
VLCFA-CoA synthetase assay. The lignoceroyl-CoA synthethase activity of the cultured amniocytes was reduced and similar as in ALD fibroblasts (Table 1) .
Since the fetus was thought to have the disease from these results, the parent elected termination of pregnancy at 20th week of gestation. The fresh liver specimen of the fetus was used for RT-PCR analysis.
RT-PCR and sequencing. Each amplified cDNA (Fig. 3) was ligated with the vector DNA. At codon 617 a G to A substitution was detected by sequencing a The activity in fibroblasts of ALD patients and normal controls were shown (mean-4-SD). 
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Two RT-PCR products ALD5/6 and ALD7/10 (with primers 5/6 and 7/10, respectively) were subcloned into vector pSPT18. Coding region is boxed.
o f the subclone ALD7/10. R T -P C R product with primer set 7/10 was digested with either A c i I or AflIII. A c i I recognizes normal sequence at codon 617, and AflIII does G to A substituted codon 617 (Fig. 4a) . cassette family of transporters (ABC transporter) (Mosser etal., 1993) . ALDP shares high homology with major 70K peroxisome membrane protein (PMP) (Kamijo et al., 1992) , which is thought to be the deficit of some types of Zellweger syndrome (Gartner et al., 1992) . These two proteins show 56~ homology over 210 amino acids at carboxy terminal region. The codon 617 in the carboxy terminal region constitutes the border between the ATP-binding site motif (NBF) and the conserved 12-amino acids segment, and this codon (arginine R) is conserved among the ABC transporters such as PMP 70K, multiple drug resistants 1 (MDR1), cystic fibrosis transmembrane conductance regulator (CFTR) and two peptide transporters (PSF1, 2) (Mosser etal., 1993) . The sequencing of the RT-PCR product in the fetus showed G to A transition at codon 617 of the reported cDNA sequence and the base substitution was confirmed by restriction endonuclease digestion. A substitution from arginine (R) to histidine (H) was deduced by this point mutation. This arginine residue is highly conserved among the ABC transporter superfamily and it seems that this region is necessary for ATP binding and, thus, for transport of the VLCFA-CoA synthetase into the peroxisome (Valle and Gartner, 1993) . It is probable that G to A transition in the codon 617 caused AMN/ALD in our family, although it is necessary to elucidate whether this R617H substitution is polymorphism and whether the function of this mutated ALDP is reduced or not. In patients with cystic fibrosis there are also some mutations in NBFs in the CFTR gene (Cutting et al., !990) , thus the ATP-binding site seems very important for these ABC transporters.
The cause of phenotypic variation of AMN/ALD within this family is not known. There may be some unknown factors or some difference in immunological response in each patient (Mosser et al., 1993) .
